Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

MAXHEALTH's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 0.79300
forwardPE 44.23476
debtToEquity 32.57900
earningsGrowth 0.74300
revenueGrowth 0.25100
grossMargins 0.62122
operatingMargins 0.21871
trailingEps 13.88000
forwardEps 22.41224

MAXHEALTH's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with MAXHEALTH expected to continue increasing its profits and revenue in the coming periods.
MAXHEALTH's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.
MAXHEALTH's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

Over time, price projections for Max Healthcare Institute Limited have gradually increased, reflecting rising confidence in the company's future performance. This upward trend suggests analysts expect Max Healthcare Institute Limited to continue on a positive growth trajectory.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


With analysts showing a buy bias for Max Healthcare Institute Limited, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning Max Healthcare Institute Limited as a safe and profitable place for investors to allocate their funds and seek growth.